HealthPlix raises over Rs 20 crore from Kalaari Capital, IDG Ventures India Ruby Khatun Khatun1 Aug 2018 10:00 AM ISTNew Delhi: Bengaluru based health tech firm HealthPlix announced raising funds worth USD 3 million (around Rs 20.6 crore) from IDG Ventures India and...
Investors turn wary on Biogen, Eisai Alzheimer's drug results Ruby Khatun Khatun1 Aug 2018 9:45 AM ISTCHICAGO/TOKYO: Shares of Eisai Co Ltd plunged as much as 21 percent after the results of its experimental Alzheimer’s drug being developed with...
China's cabinet vows tough penalties in vaccine scandal case Ruby Khatun Khatun1 Aug 2018 9:30 AM ISTSHANGHAI: China's cabinet vowed tough penalties and fines for firms and individuals involved in a vaccine safety scandal that has sparked widespread...
Aurobindo Pharma gets USFDA approval to make, market Bivalirudin injection Ruby Khatun Khatun31 July 2018 11:00 AM ISTNew Delhi: Aurobindo Pharma Limited said it got the approval of the US Food and Drug Administration (USFDA) to manufacture and market Bivalirudin...
Lupin gets EDQM nod for its Mandideep facility Ruby Khatun Khatun31 July 2018 10:30 AM ISTNew Delhi: Drug firm Lupin said it has received an attestation from European Directorate for the Quality of Medicines (EDQM) for its Mandideep...
Zydus Cadila gets USFDA approval to market Vardenafil tablets Ruby Khatun Khatun31 July 2018 10:15 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received tentative approval from the US health regulator to market Vardenafil Hydrochloride tablets used...
AstraZeneca's key lung cancer drug wins European panel thumbs-up Ruby Khatun Khatun31 July 2018 10:00 AM ISTAstraZeneca’s cancer drug Imfinzi has won a key recommendation from a European Medicines Agency (EMA) panel less than six months after the first...
Health startup Cure.fit raises Rs 824 crore in series C funding Ruby Khatun Khatun31 July 2018 10:00 AM ISTNew Delhi: Health and fitness startup Cure.fit said it has raised USD 120 million (Rs 824 crore) in a new round of funding led by IDG Ventures, Accel...
FDA declines to approve Insys Therapeutic's opioid painkiller Ruby Khatun Khatun31 July 2018 9:45 AM ISTInsys Therapeutics Inc said the U.S. Food and Drug Administration declined to approve its opioid painkiller, citing potential safety concerns.Insys’...
GSK to shut Bangladesh drug making factory by end-2018 Ruby Khatun Khatun31 July 2018 9:30 AM ISTDHAKA: GlaxoSmithKline (GSK) will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare...
Johnson and Johnson to offer Bedaquiline for $900 in India Ruby Khatun Khatun30 July 2018 5:37 PM ISTNew Delhi: As the conditional Access program with the Government of India for the provision of Bedaquiline is soon coming to an end, come 2019,...
Sun Pharma recalls over 2,500 bottles of diabetes drug from US Ruby Khatun Khatun30 July 2018 11:00 AM ISTNew Delhi: The US arm of Sun Pharmaceutical Industries is recalling over 2,500 bottles of Metformin hydrochloride extended-release tablets from...
